Visit Hologic on Booth 14 at EUROGIN 2018 to discover why the Aptima HPV assay is fast becoming
the new Gold Standard in Cervical Screening.
You are also invited to join the Hologic Satellite Lunch Symposium on
Monday 3 December, 13.00-14.15 hrs, Auditorium II
Moving women’s health forward together; Hologic delivers up to 7 years longitudinal evidence for the Aptima® HPV assay
Chaired and Introduced by:
The longitudinal clinical performance of the Aptima HPV mRNA assay in comparison to the Hybrid Capture 2 HPV DNA test in two consecutive screening rounds with a 6-year interval in Germany
Thomas Iftner, Tübingen, Germany
RNA HPV E6/E7 screening: A 3-year longitudinal co-testing study in Madrid
Rosario Granados, Madrid-Getafe, Spain
The Swedish experience with HPV mRNA testing in routine screening and longitudinal performance data up to 7 years
Ola Forslund, Lund, Sweden
The Aptima HPV assay – the health economic value delivered through reduction in false positives and unnecessary overtreatments
Elisabeth Adams, London, UK
We look forward to welcoming you to Booth 14 and to our lunch symposium.
To register for EUROGIN click here